Figure 4. Mig6 knockdown per se did not alter cells sensitivity to erlotinib.

A) Cells were transfected with either control siRNA, or siRNA targeting Mig6 and erlotinib sensitivity assay was performed. B) Cells were transfected with either control siRNA, or siRNA targeting Mig6 and immunoblot blots were performed. C) Cells were infected with MSCV-HA-Mig6 and immunoblot blots were performed. End. Mig6: endogenous Mig6. D) Erlotinib sensitivity was tested in control or HA-Mig6 expressing cells. Data are plotted as mean ± SD and values were set at 100% for untreated controls. * indicates P<0.01.